Global surveillance of cancer survival
The CONCORD programme at the London School of Hygiene & Tropical Medicine comprises epidemiological research, teaching and capacity-building in global surveillance of cancer survival. CONCORD is supported by the Union for International Cancer Control (UICC) as a programme of strategic significance for the World Cancer Declaration.
CONCORD participants can access the documents here.
CONCORD will contribute to the WHO Action Plan for non-communicable diseases, by promoting international partnerships to evaluate the effectiveness of cancer control at national, regional and global levels.
CONCORD-2 includes analysis of global variation and trends in survival for 10 cancers in adults, and childhood leukaemia, and trends in survival from 1995 to 2009. It includes over 28 million cancer patients, provided by 279 cancer registries in 67 countries. More than 2,500 data sets have been checked and analysed. Net survival estimates up to five years after diagnosis will be published for 9 countries in Africa, 8 in Central and South America, 2 in North America, 16 in Asia, 30 in Europe, and 2 in Oceania; 40 countries contributed data with 100% coverage of the national population.
The CONCORD Working Group met for the second time in June 2014 in Ottawa, Canada, during the North American Association of Central Cancer Registries (NAACCR), and the International Association of Cancer Registries (IACR) 2014 combined conferences. The agenda and presentations are available.
The CONCORD Steering Committee includes scientists and cancer patients from 15 countries, with expertise in biostatistics, epidemiology, cancer registration and public health. The Steering Committee met to review progress and consider plans for 2014 in Buenos Aires, Argentina, on 24 October 2013, shortly after the 35th Scientific Conference of the International Association of Cancer Registries.
The CONCORD programme is currently funded by 10 agencies in five countries, to the end of 2016. The programme is also endorsed by 31 national and international agencies, including WHO EURO, the Organisation for Economic Co-operation and Development (OECD) and the World Bank.
Agencies currently funding the CONCORD programme:
- Canadian Partnership Against Cancer (Toronto), two years 2013-14
- Cancer Focus Northern Ireland (Belfast), researcher seconded to London 2013-14
- Cancer Institute New South Wales (Sydney), two researchers
- Cancer Research UK (London), four years 2013-16
- Fondation de France (Paris), full-time post-doctoral researcher 2014-2015
- Centers for Disease Control and Prevention (Atlanta), three years 2012-15
- Children with Cancer UK (London), PhD student 2013-15
- Swiss Cancer League (Bern), three years 2013-16
- Swiss Cancer Research foundation (Bern), three years 2013-16
- Swiss Re (London), two years 2012-14
We held our 9th annual short course “Cancer survival: principles, methods and applications” at the London School from 30 June to 4 July 2014 with 21 students from 16 countries and 17 faculty. This course is run in collaboration with the International Agency for Research on Cancer, including exchange of faculty.